Apteryx Imaging has provided dentists and oral health specialists with advanced diagnostic imaging software and device technologies for over 20 years. Our proprietary technologies include XrayVision, XVWeb and XrayVision DCV imaging software solutions, the VELscope Vx Enhanced Oral Assessment and TUXEDO Intraoral Sensors. The Company is currently listed on the TSX Venture Exchange (TSX-V) under the symbol “LMD”, the OTCQX under the symbol “LEDIF”, as well as the Frankfurt Stock Exchange under the symbol “LME”. For more information,

LsBioPath is a medical technology company that develops products to address the unmet needs for real-time imaging of excised tissue during breast cancer surgery. LsBioPath focuses on the development of advanced real-time imaging technologies and products that will provide better patient outcomes, while reducing hospital and insurance costs. The company's initial product is the ClearEdge imaging device; a battery-operated hand-held device with a sterile single-use probe. The imaging technology is based on clinically acceptable standards of bio-impedance spectroscopy.

Part of TOLMAR Holding, Inc., Zila Pharmaceuticals, Inc. is an American company located in Phoenix, AZ. The firm manufactures medicinal products.

Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, is currently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated. Lumicell was founded in 2008 and is based in Newton, MA, USA.

OncoFluor, Inc. provides methods for imaging and treating of organs and tissues. The company is headquartered in Coronado, CA

DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom.

NovoCure GmbH, a subsidiary of NovoCure Ltd., is a company headquartered in Munich, Germany, that develops proprietary therapy. Wilhelmus C. M. Groenhuysen and Asaf Danziger are the current co-CEOs of the firm.

Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom.

Dune Medical Devices was founded in 2002 to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the ability to detect cancer in real time, this technology holds promise for a broad range of diagnostic and therapeutic applications. Surgeons who fight cancer on a daily basis must always contend with the lingering question, “Did I get it all?” It forces those who tackle breast cancer to consistently balance the imperative towards aggressive treatment with the desire to conserve tissue. A critical leveler in that struggle may be MarginProbe™ from Dune Medical. The MarginProbe™ System delivers real-time cancer detection in the OR for a simple and immediate assessment of cancer on the margin of excised tissue. In a randomized study of 300 breast cancer patients in Israel, the reoperation rate was reduced by 56% vs. standard of care when the MarginProbe System was employed.

IntraLuminal Therapeutics is a medical device company provides products for the interventional cardiologist and radiologist to cross and recanalize totally occluded arteries. The company’s platform technology has therapeutic application for various cardiovascular, surgical, neurological, carotid, and men’s and women’s health procedures. IntraLuminal Therapeutics was founded in 1997 and is based in Carlsbad, California.

The Foundation for Research & Technology – Hellas (FORTH) (Greek: Ίδρυμα Τεχνολογίας και Έρευνας - ΙΤΕ) is a research center in Greece, supervised by the Ministry for Education through its General Secretariat for Research and Technology. It consists of seven research institutes, which are located in various cities of Greece: Heraklion, Rethymno, Patras and Ioannina. The Foundation’s headquarters, as well as the central administration offices are located in Heraklion, Crete.

Light Sciences Oncology develops cancer and tumor treatment drugs. Additionally, it offers oncology drugs research and development services to treat hepatocellular carcinoma, metastatic colorectal cancer, and glioma. Light Sciences Oncology was founded in 1994 and is headquartered in Bellevue, Washington.

Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use

Biop has developed an innovative technology for the identification of cancerous and pre-cancer cells in epithelium tissues. Biop will enable point-of-care diagnosis of the entire cervix, generating a real-time map of the cervix. Patients will receive, with near certainty a diagnosis, at the time of the test, without the wait and anxiety associated with the current, inefficient process. By implementing Biop’s technology colposcopies will be faster, more comfortable and more accurate.

Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.

EMTensor developed this novel medical imaging device. Additionally, they are developing electromagnetic tomography imaging devices, the safest and smallest of all tomographic modalities. Among their applications is brain imaging for stroke patients.

Light Sciences Corp. was manufactured biopharmaceuticals and biotherapeutics products. The company was founded in 1995 and was headquartered in Snoqualmie, WA.

ABO holds an exclusive license from Northwestern University and Evanston Northwestern Healthcare to multiple pending patents.